SCHEMBL9004699

SCHEMBL9004699

O=C(NN=c1c(=O)c2ccccc2c1=O)Nc1ccc(Cl)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.48
RAB9A P51151 5/20 0.47
KMT2A Q03164 4/20 0.47
NPC1 O15118 4/20 0.47
MAPT P10636 3/20 0.47
ALDH1A1 P00352 3/20 0.47
CASP3 P42574 2/20 0.47
SENP8 Q96LD8 2/20 0.47
SENP7 Q9BQF6 2/20 0.47
SENP6 Q9GZR1 2/20 0.47
MEN1 O00255 2/20 0.47
APAF1 O14727 1/20 0.47
TDP2 O95551 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9004618 0.86 KMT2A (0.63) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9004631 0.81 SMN1; SMN2 (0.51) RAB9AKMT2ANPC1MAPTALDH1A1
SCHEMBL8856486 0.80 MAPT (0.71) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9004641 0.77 SENP6 (0.56) RAB9AKMT2ANPC1MAPTALDH1A1
SCHEMBL9004783 0.76 RAB9A (0.55) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9004741 0.76 MAPT (0.53) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9004654 0.75 KMT2A (0.51) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9004668 0.75 RAB9A (0.57) HTTRAB9AKMT2ANPC1MAPT
SCHEMBL9232385 0.75 SENP6 (0.51) RAB9AKMT2ANPC1MAPTALDH1A1
SCHEMBL9004650 0.75 MAPT (0.51) HTTRAB9AKMT2ANPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5571843-A Derivatives of indan-1,3-dione and indan-1,2,3-trione, methods of preparing them and therapeutic use thereof INNOTHERA (FR) 1996-11-05 US disclosed
EP-0566445-B1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA LAB SA (FR) 1996-02-07 EP disclosed
EP-0566445-A1 Derivatives of indane 1,3-dione and indane-1,2,3-trione, processes for their preparation and their application in therapy INNOTHERA (FR) 1993-10-20 EP disclosed
WO-1993020045-A1 INDAN-1,3-DIONE AND INDAN-1,2,3-TRIONE DERIVATIVES, PROCESSES FOR THE PREPARATION OF SAME AND THEIR APPLICATION AS THERAPEUTIC AGENTS INNOTHERA (FR) 1993-10-14 WO disclosed